Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Non-cash Items (2020 - 2025)

RxSight's Non-cash Items history spans 6 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, Non-cash Items fell 71.67% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, down 71.67%, while the annual FY2025 figure was $4.2 million, 19.24% up from the prior year.
  • Non-cash Items reached $4.2 million in Q4 2025 per RXST's latest filing, up from $4.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $15.9 million in Q1 2024 to a low of $3.0 million in Q2 2021.
  • Average Non-cash Items over 5 years is $7.5 million, with a median of $6.9 million recorded in 2022.
  • Peak YoY movement for Non-cash Items: surged 280.89% in 2024, then plummeted 75.84% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $8.8 million in 2021, then plummeted by 30.68% to $6.1 million in 2022, then skyrocketed by 36.07% to $8.3 million in 2023, then skyrocketed by 80.72% to $15.0 million in 2024, then plummeted by 71.67% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Non-cash Items are $4.2 million (Q4 2025), $4.2 million (Q3 2025), and $3.9 million (Q2 2025).